Literature DB >> 33928935

Depressive Symptoms and Suicidal Ideation Among Lawyers and Other Law Professionals.

Matthew S Thiese1, Joseph A Allen, Martha Knudson, Kim Free, Paige Petersen.   

Abstract

Law professionals are an understudied population that is integral to society. Limited research indicates lawyers experience poor mental health, decreased wellbeing, and suicidality. This cross-sectional study recruited 654 law professionals and responses to a depression scale, the patient health questionnaire 9 (PHQ-9) were compared with the general working population. Lawyers were significantly more likely to report suicidal ideation "several days" and "more than half the days" as compared with the general working population, with odds ratios (OR) of 6.54 (95% confidence interval [CI] 4.16 to 10.29) and 5.50 (95% CI 2.23 to 13.53) respectively. Lawyers were more likely reported mild (OR = 3.89, 95% CI 3.04 to 4.96), moderate (OR = 5.29, 95% CI 3.61 to 7.76), moderately severe (OR = 9.71, 95% CI 5.50 to 17.14), and severe (OR = 18.34, 95% CI 6.00 to 56.11) depressive symptoms. 17.5% of lawyers in this study were experiencing symptoms equivalent to a diagnosis of a major depressive disorder.
Copyright © 2021 American College of Occupational and Environmental Medicine.

Entities:  

Year:  2021        PMID: 33928935     DOI: 10.1097/JOM.0000000000002127

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Burnout and Engagement's Relationship to Drug Abuse in Lawyers and Law Professionals.

Authors:  Uchenna C Ogbonnaya; Matthew S Thiese; Joseph Allen
Journal:  J Occup Environ Med       Date:  2022-06-16       Impact factor: 2.306

2.  Chemokine (C-C motif) ligand 5 (RANTES) concentrations in the peripheral blood of patients with a depressive disorder.

Authors:  Elżbieta Małujło-Balcerska; Anna Kumor-Kisielewska; Janusz Szemraj; Tadeusz Pietras
Journal:  Pharmacol Rep       Date:  2022-03-16       Impact factor: 3.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.